Literature DB >> 6434149

The benzodiazepine antagonist, Ro 15-1788, increases REM and slow wave sleep in the dog.

A Wauquier, D Ashton.   

Abstract

The benzodiazepine antagonist, Ro 15-1788, increases REM and deep slow-wave in dogs at a dose of 10 mg/kg orally. These actions are opposite to that of diazepam. This suggests either that Ro 15-1788 possesses hitherto undescribed intrinsic partial inverse agonist activity or that it is antagonizing an endogenous benzodiazepine-like substance which is involved in modulating sleep-wakefulness.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6434149     DOI: 10.1016/0006-8993(84)90929-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

Review 1.  Intrinsic actions of the benzodiazepine receptor antagonist Ro 15-1788.

Authors:  S E File; S Pellow
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Effects of chlordiazepoxide training dose on the mixed agonist-antagonist properties of benzodiazepine receptor antagonist Ro 15-1788, in a drug discrimination procedure.

Authors:  J De Vry; J L Slangen
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Sleep improvement in dogs after oral administration of mioflazine, a nucleoside transport inhibitor.

Authors:  A Wauquier; H Van Belle; W A Van den Broeck; P A Janssen
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.